Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy » Volume 16 » default
Blood and Lymphatic Cancer: Targets and Therapy
- View all (140)
- Volume 16, 2026 (14)
- Volume 15, 2025 (19)
- Volume 14, 2024 (6)
- Volume 13, 2023 (7)
- Volume 12, 2022 (12)
- Volume 11, 2021 (6)
- Volume 10, 2020 (2)
- Volume 9, 2019 (7)
- Volume 8, 2018 (7)
- Volume 7, 2017 (8)
- Volume 6, 2016 (5)
- Volume 5, 2015 (11)
- Volume 4, 2014 (13)
- Volume 3, 2013 (6)
- Volume 2, 2012 (12)
- Volume 1, 2011 (5)
Archive: Volume 16, 2026
Short-Term Longitudinal Analysis of Gut Microbiota Dynamics During Anti-CD19 CAR-T Cell Therapy in Diffuse Large B-Cell Lymphoma Patients
Shen Z, Xing X, Rong K, Geng Z, Yang N, Xu L, Ge H, Sang W
Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:598958
Published Date: 1 May 2026
Poor Outcome of Pediatric Patients with Acute Lymphoblastic Leukemia Harboring Low P16 Deletion Ratio: A Post-Hoc Analysis from a Prospective Cohort
Qiu KY, Liao XY, Chen HL, Zheng H, Fang JP, Zhou DH
Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:592290
Published Date: 30 April 2026
Defining High-Risk Disease Biology in Multiple Myeloma: A Narrative Review
Aljumaa M, Hamam Refai H, Chawla Y, Gonsalves WI
Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:586948
Published Date: 27 April 2026
Enzymatic Laccase Nanoreactors Induce Apoptosis in MOLT-4-ALL Cells and Activate Prodrugs in a Synergetic Effect
Medrano-Villagómez CA, Loredo-García E, Gasperin-Bulbarela J, Vazquez-Duhalt R
Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:576292
Published Date: 27 April 2026
Venetoclax Plus Hypomethylating Agents for Treatment-Naïve Myelodysplastic Syndromes with Increased Blasts: A Prospective Multicenter Cohort Study
Zhao N, Zhu L, Hu X, Tong J, Ge H, Ye L, Zhu X, Gai C, Feng Y, Zhang L, Wang L, Sun G, Xue L, Zhu X, Zheng C
Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:592550
Published Date: 24 April 2026
Prognostic Value of the Aggregate Inflammation Systemic Index (AISI) in Patients with Diffuse Large B-Cell Lymphoma: A Multicenter Retrospective Study
Chen X, Huang L, Zhang Q, Xing X, Zhang S, Wang C, Wang L, Shen Z, Sang W
Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:571663
Published Date: 31 March 2026
Crosstalk Between FOXN3 and E2F5 Reveals a Novel Tumor Suppressive Pathway in Acute Myeloid Leukemia via MAPK Signaling: Implications for Potential Future Targeted Therapy
Zhang J, Jiang Q, Liu T, Li H, Liang Y, Lu X, Pang H, Li S, Li Y, Zhang R
Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:571966
Published Date: 24 March 2026
Health Disparities in Acute Myeloid Leukemia Patients Undergoing Treatment with Tyrosine Kinase Inhibitor (TKI) Therapy Targeting FLT3, IDH1, or IDH2
Espinoza-Gutarra MR, Jarrett BA, Wang X, Afghahi A, Bae S
Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:559759
Published Date: 12 March 2026
Construction and Validation of an N7-Methylguanosine–Related Prognostic Model for Acute Myeloid Leukemia
Wang L, Li M, Xi Y
Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:575337
Published Date: 11 March 2026
Association Between Petroleum Compounds Exposure and Risk of Childhood Leukemia: A Systematic Review
Soliman HMH, Hassan WY, Mostafa M, Gomaa MK, Soliman Jnr MH, Hussein MF
Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:571340
Published Date: 11 February 2026
Natural Killer/T-Cell Lymphoma-Associated Hemophagocytic lymphohistiocytosis—a Rare and Dangerous Disease
Meng G, Wang M, Sun C, Feng G, Ren J, Feng S, Wang Y
Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:574445
Published Date: 27 January 2026
Safety and Efficacy of Flumatinib in Patients with Chronic Phase Chronic Myeloid Leukemia: A Real-Life Cohort Observational Study
Cheng F, Cui Z, Li Q, Wang L, Li W
Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:573070
Published Date: 22 January 2026
Study on the Role of Neutrophil Extracellular Traps-Based Risk Model and Discriminative Gene LTF in the Prognosis of Acute Myeloid Leukemia and the Regulation of Immune Microenvironment
Li Y, Zhang J, Liu T, Zhang D, Wang N, Liu X, Feng P, Zhang J, Ji C, Ye J
Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:562651
Published Date: 13 January 2026
Global Patterns, Temporal Trends, and Potential Non-Infectious Risk Factors for Burkitt Lymphoma from 1990 to 2021
Jin SK, Lyu JT, Feng ZY, Zhang SQ, Lu BY, Yan QF, Li J, Du J, Huang ZF
Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:556459
Published Date: 8 January 2026